Connect with us

INTERNACIONAL

UCLA medical school hit with class-action lawsuit for allegedly still using race-based admissions process

Published

on


The University of California, Los Angeles, medical school was hit with a class-action lawsuit on Thursday for reportedly still employing a race-based admissions process despite a 2023 Supreme Court ruling that race-based programs for college admissions are unconstitutional, Fox News Digital has learned. 

«UCLA’s Geffen School of Medicine has continually treated the Students for Fair Admissions ruling as a recommendation, rather than a binding law handed down by the highest court in the land,» Dr. Stanley Goldfarb, chair of Do No Harm, told Fox News Digital. «Do No Harm is fighting for all the students who have been racially discriminated against by UCLA under the guise of political progress. All medical schools must abide by the law of the land and prioritize merit, not immutable characteristics, in admissions.»

Advertisement

Do No Harm, a nonprofit organization dedicated to fighting against «radical progressive ideology» in the health industry, and nonprofit legal advocacy organization Students for Fair Admissions filed the class-action lawsuit Thursday afternoon on behalf of applicants who allegedly faced «intentional discrimination on the basis of race and ethnicity in the admissions process» at UCLA’s medical school, according to the lawsuit.

WATCH: UNEARTHED FOOTAGE EXPOSES MEDICAL SCHOOL ADMINISTRATORS PLEDGING TO RESIST TRUMP EXECUTIVE ORDERS

Royce Hall on the campus of UCLA. (iStock)

Advertisement

«The numbers show that UCLA is engaged in intentional racial balancing. Between 2020 and 2023, the percentage of white and Asian applicants to Geffen was consistently around 73% of the total applicant pool. Yet, the percentage of matriculants to Geffen who are white and Asian plummeted: 65.7% in 2020, 57.1% in 2021, 57.8% in 2022, and 53.7% in 2023,» the lawsuit alleges. 

UCLA’s medical school is highly competitive with an acceptance rate of about 3.3%, according to U.S. News and World Report’s college rankings.

MORE THAN HALF OF AMERICAN HOSPITALS HAVE PLANS TO INCREASE RACIAL DIVERSITY AMONG LEADERSHIP, STUDY SAYS

Advertisement

The suit names a bevy of defendants, ranging from the medical school to the governing board of the University of California’s college system to the associate dean of admissions at the medical school. 

Fox News Digital reached out to UCLA and the David Geffen School of Medicine at UCLA on Thursday afternoon for comment on the lawsuit but did not immediately receive replies.

Supreme Court

The Supreme Court ruled in 2023 that it is unconstitutional to use race-based affirmative action programs. (Drew Angerer/Getty Images)

The suit alleges that the medical school’s admissions process violates the Supreme Court’s ruling in the 2023 case, Students for Fair Admissions v. Harvard. The nation’s highest court ruled that it is unconstitutional to use race-based affirmative action programs in college admissions processes as it violates the Equal Protection Clause of the Fourteenth Amendment. 

Advertisement

President Donald Trump additionally signed an executive order on Jan. 21, one day after his inauguration, that restored «merit-based opportunity» and charged federal agencies with enforcing civil rights laws and «combat» DEI practices. 

AG BONDI LAUNCHES INVESTIGATION INTO DEI ADMISSIONS POLICIES AT STANFORD, UNIVERSITY OF CALIFORNIA SCHOOLS

The lawsuit alleges that whistleblowers «with first-hand knowledge» of the school’s dean of admissions rolled out an admissions process plan that requires Geffen «applicants to submit responses that are intended to allow the Committee to glean the applicant’s race, which the medical school later confirms via interviews.»

Advertisement

The admission committee, according to the suit, additionally «routinely and openly discuss race (and racial proxies) and use race as a factor to make admission decisions.»

LIBERAL IDEOLOGY ‘QUITE DANGEROUS’ IN HEALTH CARE, DO NO HARM FOUNDER SAYS: ‘POISONS THE AMERICAN EXPERIENCE’

The David Geffen School of Medicine at UCLA is already facing investigation by the Department of Health and Human Services’ Office for Civil Rights over allegations it discriminates against applicants on the basis of race, color or national origin.

Advertisement
Secretary of Health and Human Services Robert F. Kennedy Jr.

Secretary of Health and Human Services Robert F. Kennedy Jr. (Alex Wong/Getty Images)

«This investigation reflects the Administration’s commitment to honor the hard work, excellence, and individual achievement of all students in the pipeline for the medical profession – not just those of particular racial backgrounds,» Anthony Archeval, acting director of the Office for Civil Rights at HHS, said in a press release in March announcing the investigation.

CLICK HERE TO GET THE FOX NEWS APP

The HHS investigation was sparked by multiple whistleblowers in the admissions office claiming that the school set lower standards for Black and Latino applicants compared to White and Asian counterparts, the Washington Free Beacon reported this month.

Advertisement

Supreme Court,Donald Trump,California,Healthcare

INTERNACIONAL

Justice Department investigating University of California over alleged DEI-based hiring

Published

on


NEWYou can now listen to Fox News articles!

The Justice Department has announced it is investigating the University of California (UC) for alleged Title VII discrimination violations in its hiring practices.

Advertisement

The agency announced Thursday that its Civil Rights Division is looking into the university’s individual campuses regarding potential race- and sex-based discrimination in employment practices.

The university’s «UC 2030 Capacity Plan» directs its campuses to hire «diverse» faculty members to meet race- and sex-based employment quotas, the Justice Department said.

The Justice Department has launched a Title VII investigation into the University of California over alleged race- and sex-based discrimination in faculty hiring. (AP Photo/Ben Margot, File)

Advertisement

UNIVERSITY OF MICHIGAN, LAW JOURNAL SUED FOR ALLEGEDLY DISCRIMINATING AGAINST STRAIGHT WHITE MALES 

«These initiatives openly measure new hires by their race and sex, which potentially runs afoul of federal law,» the Justice Department said in a press release. 

«The Civil Rights Division’s Employment Litigation Section will investigate whether the University of California is engaged in a pattern or practice of discrimination based on race, sex, and other protected characteristics, pursuant to Title VII of the Civil Rights Act of 1964.»

Advertisement

Title VII prohibits an employer from discriminating against an individual on the basis of race, color, religion, sex, or national origin, Harmeet Dhillon, the assistant attorney general of the Justice Department’s Civil Rights Division, said.

«Public employers are bound by federal laws that prohibit racial and other employment discrimination,» Dhillon said. «Institutional directives that use race- and sex-based hiring practices expose employers to legal risk under federal law.»

The Justice Department’s Civil Rights Division wrote to the university on Thursday, informing it of the investigation. 

Advertisement

«Our investigation is based on information suggesting that the University of California may be engaged in certain employment practices that discriminate against employees, job applicants, and training program participants based on race and sex in violation of Title VII,» the letter reads. 

«Specifically, we have reason to believe the University of California’s ‘UC 2030 Capacity Plan’ precipitated unlawful action by the University of California and some or all its constituent campuses.»

woman sitting in classroom with laptop next to words "diversity equity inclusion"

In March, UC dropped diversity statements from its hiring practices amid President Donald Trump’s threats that schools could lose federal funding. (iStock)

TRUMP ADMINISTRATION TARGETS IVY LEAGUE SCHOOL, LAW JOURNAL FOR RACIAL DISCRIMINATION

Advertisement

UC said it will work in good faith with the Justice Department as it conducts its investigation.

«The University of California is committed to fair and lawful processes in all of our programs and activities, consistent with federal and state anti-discrimination laws,» a UC statement provided to Fox News Digital reads. «The University also aims to foster a campus environment where everyone is welcomed and supported.»

The university’s UC 2030 Capacity Plan lays out a goal of becoming a national model as a Hispanic-Serving Institution (HSI) and Minority-Serving Institution (MSI) system. The plan outlines a pipeline strategy to diversify faculty and researchers through expanded graduate enrollment and outreach to institutions that serve underrepresented students. The DOJ, however, claims these initiatives may violate Title VII by functioning as de facto employment quotas.

Advertisement

In March, UC dropped diversity statements from its hiring practices amid President Donald Trump’s threats that schools could lose federal funding. 

The university’s provost, Katherine S. Newman, sent out a letter to the system’s leaders informing them that diversity statements are no longer required for new applicants. Newman wrote that while some programs and departments have required them, the university has never had a policy of diversity statements and believes it could harm applicant evaluation.

University of California, Berkeley campus

University of California, Berkeley entrance sign on the corner of Oxford Street and Center Street. (iStock)

CLICK HERE TO GET THE FOX NEWS APP

Advertisement

«The requirement to submit a diversity statement may lead applicants to focus on an aspect of their candidacy that is outside their expertise or prior experience,» the letter obtained by Fox News Digital reads.

She added that employees and applicants can still reference accomplishments related to diversity, equity and inclusion (DEI) on their own, but requiring stand-alone diversity statements is no longer permitted. 

Fox News’ David Spunt and Lindsay Kornick contributed to this report

Advertisement

Continue Reading

INTERNACIONAL

Iranian foreign minister reiterates ‘serious damage’ to nuclear facilities, despite ayatollah’s comments

Published

on


NEWYou can now listen to Fox News articles!

Iranian Foreign Minister Abbas Araghchi admitted in an interview on state TV that the U.S.’s strikes caused serious damage to Tehran’s nuclear facilities, despite Ayatollah Ali Khamenei’s insistence that there was minimal impact.

Advertisement

Araghchi said in the interview that «the level of damage is high, and it’s serious damage,» according to the Associated Press.

Post-strike assessments have shown that Iran’s nuclear sites suffered damage in both U.S. and Israeli attacks. All three countries — Iran, Israel and the U.S. — have reached similar conclusions about the extent of the damage, despite what a leaked intel report indicated.

Iranian Foreign Minister Abbas Araghchi contradicts Ayatollah Ali Khamenei on the extent of damage caused by U.S. strikes on the country’s nuclear facilities. (Associated Press)

Advertisement

IRAN, ISRAEL AND US AGREE THAT ISLAMIC REPUBLIC NUCLEAR SITES WERE ‘BADLY DAMAGED’ DESPITE LEAKED INTEL REPORT

The only leader who seemingly does not agree with the assessments is Ayatollah Ali Khamenei, who said that «the Americans failed to achieve anything significant in their attack on nuclear facilities,» according to reports. 

Khamenei appears to be more focused on projecting strength than reflecting reality. He described Iran’s attack on Al-Udeid, the American airbase in Qatar, as a «heavy slap to the U.S.’s face.» While President Donald Trump dismissed it as a «very weak response» and thanked Iran for giving the U.S. «early notice.»

Advertisement

International Atomic Energy Agency (IAEA) Director General Rafael Grossi said in a statement on Tuesday that the agency had «seen extensive damage at several nuclear sites in Iran, including its uranium conversion and enrichment facilities.»

damage at the Fordow enrichment facility

This satellite picture by Planet Labs PBC shows Iran’s underground nuclear enrichment site at Fordo following U.S. airstrikes targeting the facility, on Sunday, June 22, 2025. (Planet Labs PBC via AP)

IRAN TRYING TO ‘SAVE FACE’ FOLLOWING US STRIKE ON NUCLEAR SITES, EXPERT SAYS

In addition to discussing the damage done to Iran’s nuclear sites, Araghchi also addressed the possibility of resuming talks with the U.S. He said that the American strikes «made it more complicated and more difficult» for Iran to come to the table, but did not rule out the possibility that negotiations could resume.

Advertisement

Nuclear talks with the U.S. might not be entirely off the table for Iran after last week’s strikes—even if Tehran is not interested in reentering negotiations right away.

The possibility of negotiations was already in question prior to Operation Midnight Hammer, as Tehran viewed the U.S. as being «complicit» in Israel’s Operation Rising Lion, according to Reuters, citing Iranian U.N. Ambassador Ali Bahreini.

President Trump Delivers Address

US Vice President JD Vance, from left, US President Donald Trump, Marco Rubio, US secretary of state, and Pete Hegseth, US secretary of defense, during an address to the nation in the East Room of the White House in Washington, DC, US, on Saturday, June 21, 2025.  (Carlos Barria/Reuters/Bloomberg via Getty Images)

EX-SECRETARY OF STATE CONDOLEEZZA RICE CALLS US STRIKES ON IRAN A ‘SHOT IN THE ARM’ FOR AMERICAN CREDIBILITY

Advertisement

Trump on Wednesday expressed optimism in the U.S.’s ability to resume nuclear talks with Iran.

«We’re going to talk to them next week, with Iran. We may sign an agreement, I don’t know. To me, I don’t think it’s that necessary. I mean, they had a war. They fought. Now they’re going back to their world. I don’t care if I have an agreement or not. The only thing we would be asking for is what we’re asking for before about, we want no nuclear [program]. But we destroyed the nuclear,» Trump said. 

Despite Trump’s statement, there is still no clear indication that the countries have plans to meet in the near future.

Advertisement

CLICK HERE TO GET THE FOX NEWS APP

The Associated Press contributed to this report.

Advertisement


Advertisement
Continue Reading

INTERNACIONAL

Terapia psicodélica aprobada en Nueva Zelanda. Él es el único médico que puede realizarla

Published

on


El Dr. Cameron Lacey lleva años estudiando cómo los psicodélicos podrían ayudar a tratar la depresión y otros trastornos del estado de ánimo.

La semana pasada, se convirtió en el primer y único psiquiatra de Nueva Zelanda autorizado para recetar psilocibina, el alucinógeno presente en los hongos alucinógenos.

Advertisement

La aprobación del Ministerio de Salud de Nueva Zelanda es el último impulso a un creciente movimiento global para estudiar y utilizar psicodélicos como la psilocibina y el MDMA, relegados durante mucho tiempo a los márgenes de la psiquiatría, para tratar la depresión, el trastorno de estrés postraumático y el abuso de sustancias.

Según el Ministerio de Salud, Lacey fue seleccionado por su amplia experiencia en el uso seguro de psilocibina para el tratamiento psiquiátrico durante ensayos clínicos.

Comentó que en 2021 comenzó a investigar un ensayo clínico con psilocibina tras observar que muchos de sus pacientes no respondían a los antidepresivos.

Advertisement

El gobierno ha declarado que los tratamientos con psilocibina estarán estrictamente controlados.

Un vendedor embolsa setas de psilocibina en un mercado emergente de cannabis en Los Ángeles. A pesar de las condiciones pandémicas que hicieron casi imposible la recogida normal de firmas, los activistas de la capital del país dicen tener suficientes firmas para una iniciativa electoral en noviembre que despenalizaría los psicodélicos naturales como la mescalina y las setas de psilocibina. (AP Photo/Richard Vogel, File)

Los pacientes no podrán simplemente irse de una cita con una tableta o mezcla que contenga psilocibina, que Nueva Zelanda aún clasifica como una droga ilegal, junto con la heroína y la cocaína.

En cambio, dijo Lacey, recibirán su primera dosis después de tres sesiones de terapia de conversación.

Advertisement

Luego, acostados o sentados en un sillón reclinable, con antifaces y auriculares con cancelación de ruido, los pacientes recibirán 25 miligramos de psilocibina en una cápsula.

La experiencia alucinógena, o viaje, comienza unos 45 minutos después, dijo, mientras se escuchan sonidos de la naturaleza y música tradicional maorí por los auriculares.

El viaje dura unas ocho horas.

Advertisement

“Las personas pueden experimentar todo un caleidoscopio de emociones, y eso puede ser bastante intenso, a veces bastante desafiante”, dijo Lacey en una entrevista telefónica.

Como con cualquier alucinógeno, añadió, los viajes pueden ser difíciles o perturbadores, y algunos pacientes se sienten nerviosos el día de la dosis porque esperan una experiencia intensa.

En casos raros, los pacientes pueden continuar experimentando alucinaciones después de terminar el viaje.

Advertisement

«Puede ser una experiencia angustiosa, ya que las personas continúan reviviendo algunas de las experiencias que tuvieron durante la dosis de psilocibina», dijo.

En las sesiones de terapia posteriores al viaje, los pacientes hablan sobre los sentimientos y recuerdos que experimentaron mientras tomaban psilocibina y que podrían ser la causa de su depresión, explicó Lacey.

Durante su ensayo clínico con psilocibina, dos tercios de los participantes mostraron una reducción de los síntomas de depresión, añadió.

Advertisement

El programa de tratamiento tiene una duración de 10 a 12 semanas, añadió Lacey.

La investigación de Lacey se inspiró en parte en los maoríes, el pueblo indígena de Nueva Zelanda, cuyo enfoque holístico de la salud ha sido otro de los ejes de su investigación.

Algunos pueblos indígenas, incluidos los maoríes, han utilizado ciertos hongos para fomentar una profunda introspección durante rituales y ceremonias tradicionales y para curar trastornos mentales, según investigadores de la psilocibina.

Advertisement

El trabajo de Lacey podría allanar el camino para una aprobación más amplia, que también podría permitir a las aseguradoras de salud considerar cubrir la terapia con psilocibina.

Legalización

En 2023, la vecina Australia legalizó el uso de psilocibina y MDMA, el estimulante más comúnmente conocido como éxtasis, para tratar la depresión y el trastorno de estrés postraumático.

Advertisement

En Estados Unidos, la psilocibina está clasificada como sustancia de la Lista I por el gobierno federal, una designación para drogas con alto potencial de abuso y sin usos médicos actualmente aceptados.

Sin embargo, se están realizando múltiples ensayos clínicos en EE.UU. para estudiar su potencial para tratar la adicción y la depresión.

La creciente popularidad de la psilocibina se debe en parte a ensayos clínicos exitosos como el de Lacey y a su menor potencial de adicción o sobredosis en comparación con otros alucinógenos como la ketamina.

Advertisement

Estudios también han demostrado que el efecto antidepresivo de la ketamina desaparece con el tiempo, lo que podría conducir al abuso.

Sin embargo, el tratamiento con psilocibina de Lacey no es económico.

El programa de 10 semanas puede costar entre 16.000 y 19.500 dólares.

Advertisement

A pesar del elevado precio, comentó, otros psiquiatras lo habían contactado para ofrecer el tratamiento a sus pacientes, quienes previamente habían considerado viajar a otros países para recibir terapia con psilocibina.

El sistema de salud de Nueva Zelanda cubre el tratamiento y los medicamentos de salud mental completamente aprobados.

Además, Lacey señaló: «Existe un alto costo personal por el deterioro y la discapacidad que han sufrido debido a experiencias de depresión y otras afecciones que no mejoran por completo».

Advertisement

c.2025 The New York Times Company

Continue Reading

LO MAS LEIDO

Tendencias

Copyright © 2025 NDM - Noticias del Momento | #Noticias #Chimentos #Política #Fútbol #Economía #Sociedad